Maintain TXN at Hold; upgrade hedge to 2.5–3% via $280/$260 put spread, hold $271 stop, let Q3 earnings Oct 21 be the resolution catalyst
Consensus HOLD is correct given extended multiples (27× forward EPS, 13% above 2022 cycle peak $9.41), 89% recovery captured, and binary event 14 days out. Aggressive analyst wins the current-state argument (strong Q2 actuals, bullish technicals, FCF inflection). Conservative analyst wins the forward-setup argument (no margin of safety at current multiples, Polymarket signal is noise, October rally on light volume, beta 1.34 contradicts defensive framing, $299 resistance already rejected). Prior-decision framework confirms: the 10/06 Hold without pre-committed hedge bled -2.5% alpha, requiring the sizing correction to 2.5–3%. The 10/05 Underweight (+0.2%) confirms trim magnitude was too heavy; the 10/02 Overweight (-0.3%) confirms adding into binary catalyst bleeds alpha even with disciplined sizing; the 10/01 Overweight (+3.7%) confirms the 35–40% sizing + time-stop + scale-in framework works when thesis is working. None of those frameworks apply cleanly at $289 with 14 days to Q3 print on stretched multiples. The Neutral analyst's framework — hold position, hold stop, upgrade hedge, alert at $299, no add or trim — is the highest-EV expression. Price target $289 reflects current level; stop at $271.
| Position | Action |
|---|---|
| Daily close below $271 (50 SMA) | Reassess toward Underweight |
| Q3 beat + Q4 conviction guide | Upgrade to Overweight on next-day weakness |
| Q3 beat + in-line-to-soft guide | Stay Hold |
| Q3 miss or weak guide | Downgrade to Underweight with 30–50% trim on gap reaction |
| Clean break above $324 May high on 8M+ shares | Revisit toward Overweight |
TXN's Q2'26 operating leverage inflection—evidenced by reported +23.5% revenue growth, 61.4% gross margins, 42.6% operating margins, and a 60% CapEx collapse—combined with six bullish technical alignments and a 79% earnings beat probability, makes the forward P/E of 27× anchored to delivered results rather than hope, making HOLD a missed opportunity.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 285.34 | bullish |
| close_50_sma | 271.38 | bullish |
| close_200_sma | 248.98 | bullish |
| rsi | 61.72 | neutral |
| macd_line | 6.66 | bullish |
| macd_signal | 3.98 | bullish |
| macd_histogram | +2.68 | bullish |
| bollinger_upper | 299.06 | neutral |
| bollinger_middle | 274.99 | neutral |
| bollinger_lower | 250.91 | neutral |
| atr_14 | 8.11 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Clean break above $324 May high on 8M+ shares
Then: Revisit toward Overweight
Forward P/E of 27× is anchored to delivered results, not forecasts
↩ rebuts: “Bear's 'forward P/E of 27× is rich' critique”
EV: +12% · concedes: The macro is uncertain: 2002-high Treasury yields, 96% probability of no Fed cuts in 2026, sticky inflation, Iran-war oil channel; The bear's 'wait for clarity' approach is not without merit as a risk management principle, but it is mathematically equivalent to buying higher or never buying
TXN is a late-cycle trap where investors are overpaying for a cyclical recovery that has already largely run its course; the risk/reward is asymmetric to the downside.
EV: $258 (target) · concedes: Q2'26 was a genuine beat with strong fundamentals; Current TXN has better margins than at May peak; The bull correctly identified the April blow-off day as institutional buying; Q3'26 has an easy YoY comp
→ vs conservative: 27× forward EPS is not 'stretched'—PEG 1.06 represents fair value for a company printing 61.4% gross margins and 42.6% operating margins with structural FCF inflection
→ vs conservative: 89% recovery claim is wrong—forward EPS $10.64 hasn't even exceeded prior cycle peak $9.41, and $800M+ FCF tailwind is just beginning to impact the model
→ vs conservative: Binary event framing into 79% beat probability is a mental model that causes traders to miss 30% moves by fading positive expected value setups
→ vs neutral: Technical setup is not 'mixed signals'—every indicator (10-EMA > 50-SMA > 200-SMA, MACD +2.68, RSI 61.72) is aligned in bullish regime, calling it neutral is missing a coiled spring
→ vs neutral: 'Preserve gains and wait for resolution' is dressed-up fear of volatility; the 50-SMA at 271.38 provides 6%+ cushion and the stop is already aligned with chart structure
→ vs neutral: Quiet news flow in high-quality names with operational momentum represents institutional accumulation, not distribution—rising VWMA on recent sessions confirms it
| neutral |
| vwma | 275.72 | bullish |
Support: 250.91 · 258 · 260 · 271.38 · 274.99 · 285.34 | Resistance: 299.06 · 307 · 314
TXN exhibits a textbook short-term bullish trend within a confirmed longer-term uptrend. The bullish MA stack (10>50>200), constructive RSI at 61.72, and expanding MACD histogram support continuation. However, price is elevated near the upper Bollinger band at 299.06 (~10 points above current 288.98 close) and volume has been moderate rather than blow-off on the October rally, creating a watch scenario. Key support layers are at 285.34 (10 EMA), 274.99 (Bollinger middle), and 271.38 (50 SMA). A close above 299.06 on expanding volume would confirm the breakout; a close below 285.34 would be the first short-term warning.
Market Capitalization
$263.91B
P/E Ratio (TTM)
43.98×
Forward P/E
27.15×
PEG Ratio
1.06
Price-to-Book
14.65×
EPS (TTM)
$6.57
Forward EPS
$10.64
Dividend Yield
2.05%
Beta
1.34
52-Week High
$334.03
52-Week Low
$152.73
Implied Price
$288.93
Revenue (TTM)
$19.45B
Gross Profit (TTM)
$11.35B
Gross Margin (TTM)
~58.3%
EBITDA (TTM)
$9.52B
EBITDA Margin (TTM)
~48.9%
Operating Margin (TTM)
42.6%
Net Income (TTM)
$6.02B
Profit Margin (TTM)
31.1%
Return on Equity
35.2%
Return on Assets
13.1%
Free Cash Flow (TTM)
$3.55B
Revenue FY2022
$20.03B
Revenue FY2023
$17.52B
Revenue FY2024
$15.64B
Revenue FY2025
$17.68B
Net Income FY2022
$8.75B
Net Income FY2023
$6.51B
Net Income FY2024
$4.80B
Net Income FY2025
$5.00B
Diluted EPS FY2022
$9.41
Diluted EPS FY2023
$7.07
Diluted EPS FY2024
$5.20
Diluted EPS FY2025
$5.45
FCF FY2022
$5.92B
FCF FY2023
$1.35B
FCF FY2024
$1.50B
FCF FY2025
$2.60B
CapEx FY2022
$2.80B
CapEx FY2023
$5.07B
CapEx FY2024
$4.82B
CapEx FY2025
$4.55B
Dividends FY2022
$4.30B
Dividends FY2023
$4.56B
Dividends FY2024
$4.80B
Dividends FY2025
$5.00B
Buybacks FY2022
$3.62B
Buybacks FY2023
$293M
Buybacks FY2024
$929M
Buybacks FY2025
$1.48B
R&D FY2022
$1.67B
R&D FY2023
$1.86B
R&D FY2024
$1.96B
R&D FY2025
$2.08B
Revenue Q2'26
$5.46B
Gross Margin Q2'26
61.4%
Operating Margin Q2'26
42.6%
Diluted EPS Q2'26
$2.14
FCF Q2'26
$2.19B
Revenue Q1'26
$4.83B
Revenue Q4'25
$4.42B
Revenue Q3'25
$4.74B
Revenue Q2'25
$4.45B
Cash + ST Investments Q2'26
$7.00B
Total Debt Q2'26
$14.05B
Net Debt Q2'26
$10.39B
Current Ratio Q2'26
4.86
Debt/Equity Q2'26
78.0%
Stockholders' Equity Q2'26
$18.01B
Treasury Stock
$41.9B
Gross PP&E
$17.86B
Accumulated Depreciation
$5.95B
Inventory Q2'26
$4.61B
Strengths
Concerns
Texas Instruments is executing a textbook cyclical recovery in Q2 2026, with revenue of $5.46B (+22.8% YoY), expanding gross margins to 61.4%, and EPS of $2.14 as CapEx rolls off and FCF inflects to $2.19B. The company maintains exceptional fundamentals with $7.0B in liquidity, a 4.86 current ratio, 35.2% ROE, and 42.6% operating margins, while the $41.9B treasury stock balance reflects decades of disciplined capital return. However, the stock trades at a premium forward P/E of 27× pricing in ~62% EPS growth recovery that leaves limited room for disappointment, and with a beta of 1.34 and historical cyclical drawdowns of ~30% following peaks, near-term volatility is a risk despite the high-quality, dividend-growing analog franchise appropriate for long-term holders.
Macro: 10-Year Treasury yield at highest level since 2002; 30-Year at highs last seen in 2002; Fed funds: 96% probability of NO rate cuts in 2026 (volume $8.8M, down -1.1pp WoW); US recession probability: 6% (down 2pp); S&P 500/Nasdaq at record highs as of Oct 6; Bitcoin below $83,000; Mortgage rates at 7.58% (3-year high); CPI cooler-than-expected in late September; Polymarket Q3 earnings beat: 79% Yes (resolves 2026-10-21, volume $363)